Dr. Ze-Yang Ding is a Professor of Hepatobiliary Surgery at the Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology at Wuhan, China. Dr. Ding’s research focuses on the molecular and cellular mechanisms of the metastasis, immune evasion and targeted therapy of liver cancer. His research focuses on the epigenetic mechanisms on the progression of liver cancer, and precision treatment of liver cancer. He have more than 78 publications, including peer-reviewed research articles, reviews, book chapters, and patent applications. His publications have been remarked in articles published in Science Immunology, Gut, Hepatology, Journal of Hepatology and were cited by articles in British Medical Journal, Nature Reviews of Gastroenterology and Hepatology, Cell Metabolism, etc. (with 1485 citations, Google Scholar's H-index of 23). His publication was on the most frequently cited articles of Elsevier in 2022. He has served on the editorial board of Hepatoma Research (Academic Editor) since 2024, on the editorial board of Journal of Clinical and Translational Hepatology (Academic Editor) since 2021, as a peer reviewer of the Journal of Hepatology since 2023. Also, he has served as an ad-hoc reviewer for many other journals including Advanced Science, Theranostics, etc. and grant agencies such as NSFC grant of China. He is investigating markers that could predict the efficacy of immunotherapy of cancer, and targets that could enhance the the efficacy of immunotherapy in cancer. He showed advantages in Communication, Mentoring and Problem-solving, and he is member of Hepatobiliary Pancreatic MDT Professional Committee of the International Hepatobiliary Pancreatic Association China Branch, Clinical Collaboration Group for Liver Cancer (CCGLC) of the International Hepatobiliary Pancreatic Association China Branch, member and secretary of the Portal Hypertension Expert Working Group of the Surgery Branch of the Chinese Medical Doctor Association, member of the Liver Youth Expert Working Group of the Surgery Branch of the Chinese Medical Doctor Association, Liver Cancer Professional Committee of the Chinese Anti Cancer Association, Endoscopic and Robotic Surgery Branch of the Chinese Anti Cancer Association. He like playing tennis and golf. His research focuses on the epigenetic mechanisms on the progression of liver cancer, and precision treatment of liver cancer. He have more than 78 publications, including peer-reviewed research articles, reviews, book chapters, and patent applications. His publications have been remarked in articles published in Science Immunology, Gut, Hepatology, Journal of Hepatology and were cited by articles in British Medical Journal, Nature Reviews of Gastroenterology and Hepatology, Cell Metabolism, etc. (with 1485 citations, Google Scholar's H-index of 23). His publication was on the most frequently cited articles of Elsevier in 2022. He has served on the editorial board of Hepatoma Research (Academic Editor) since 2024, on the editorial board of Journal of Clinical and Translational Hepatology (Academic Editor) since 2021, as a peer reviewer of the Journal of Hepatology since 2023. Also, he has served as an ad-hoc reviewer for many other journals including Advanced Science, Theranostics, etc. and grant agencies such as NSFC grant of China. He is investigating markers that could predict the efficacy of immunotherapy of cancer, and targets that could enhance the the efficacy of immunotherapy in cancer. He showed advantages in Communication, Mentoring and Problem-solving, and he is member of Hepatobiliary Pancreatic MDT Professional Committee of the International Hepatobiliary Pancreatic Association China Branch, Clinical Collaboration Group for Liver Cancer (CCGLC) of the International Hepatobiliary Pancreatic Association China Branch, member and secretary of the Portal Hypertension Expert Working Group of the Surgery Branch of the Chinese Medical Doctor Association, member of the Liver Youth Expert Working Group of the Surgery Branch of the Chinese Medical Doctor Association, Liver Cancer Professional Committee of the Chinese Anti Cancer Association, Endoscopic and Robotic Surgery Branch of the Chinese Anti Cancer Association. He like playing tennis and golf.